To further confirm the requirement for CCR5 in fibrosis resolution, we generated HSC-specific CCR5 deficient mice by administrating vitamin A-CCR5 siRNA liposomes during the NASH resolution phase (Fig. 7f). The gene discussed is CCR5; the disease is metabolic dysfunction-associated steatohepatitis.